Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease.

Magnetic resonance imaging (MRI)-based volumetric measurements of medial temporal lobe (MTL) structures can discriminate between normal elderly control subjects and patients with Alzheimer's disease (AD) of moderate to advanced severity. In terms of clinical utility, however, a more important issue concerns the ability of the technique to differentiate between normal elderly control subjects and AD patients with the very mildest form of the disease. We performed MRI-based volumetric measurements of the hippocampus, parahippocampal gyrus, and amygdala in 126 cognitively normal elderly control subjects and 94 patients with probable AD. The diagnosis of AD was made according to NINDS/ADRDA criteria, and disease severity was categorized by Clinical Dementia Rating (CDR) scores. Patients with CDR 0.5 were classified as very mild, CDR 1 as mild, and CDR 2 as moderate disease severity. Volumes of each structure declined with increasing age in control subjects and did so in parallel for men and women. The volume of each measured MTL structure also declined with age in patients with AD. The volume of each MTL structure was significantly smaller in AD patients than control subjects (p < 0.001). Of the several MTL measures, the total hippocampal volumetric measurements were best at discriminating control subjects from AD patients. The mean hippocampal volumes for AD patients relative to control subjects by severity of disease were as follows: very mild AD (CDR 0.5) -1.75 SD below the control mean, mild AD (CDR 1) -1.99 SD, and moderate AD (CDR 2) -2.22 SD. Age- and gender-adjusted, normalized MRI-based hippocampal volumetric measurements provide a sensitive marker of the MTL neuroanatomic degeneration in AD early in the disease process.

Pubmed ID: 9305341


  • Jack CR
  • Petersen RC
  • Xu YC
  • Waring SC
  • O'Brien PC
  • Tangalos EG
  • Smith GE
  • Ivnik RJ
  • Kokmen E



Publication Data

September 10, 1997

Associated Grants

  • Agency: NIA NIH HHS, Id: AG-06786
  • Agency: NIA NIH HHS, Id: AG-08031
  • Agency: NIA NIH HHS, Id: AG11378
  • Agency: NIA NIH HHS, Id: P30 AG008031-089003
  • Agency: NIA NIH HHS, Id: R01 AG011378
  • Agency: NIA NIH HHS, Id: R01 AG011378-07
  • Agency: NIA NIH HHS, Id: U01 AG006786
  • Agency: NIA NIH HHS, Id: U01 AG006786-14

Mesh Terms

  • Aging
  • Alzheimer Disease
  • Amygdala
  • Atrophy
  • Female
  • Hippocampus
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Severity of Illness Index
  • Temporal Lobe